Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Nexgen Plant Science Center LLC has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners. Both examiners are located within 1 distinct art unit, which suggests that the company's biotechnology innovations are being reviewed by a single specialized department. This concentration in 1 distinct art unit may provide a more consistent technical evaluation for the pending cases.
STANKOVIC, BRATISLAV is the busiest examiner for the portfolio. This examiner is responsible for 1 busiest examiner pending office action. The 2 pending actions are divided between the 2 distinct examiners. This means that while the company must manage 2 different examiner relationships, both examiners are subject to the same art unit policies. This balance of examiner variety and art unit focus is a central feature of their current prosecution. Practitioners should be prepared for 2 different examination styles within this 1 technical group. This structure allows for departmental consistency across both actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STANKOVIC, BRATISLAV | 1 | 70.0% | +21.9% |
| KOVALENKO, MYKOLA V | 1 | 69.6% | +25.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19216147 | SEXUAL KENTUCKY BLUEGRASS CULTIVARS AND BREEDING STRATEGIES | STANKOVIC, BRATISLAV | — |
| 18232269 | HEXAPLOID-OCTOPLOID PERENNIAL RYEGRASS, HEXAPLOID-OCTOPLOID RYEGRASS AMERICAN RYEGRASS, AND HYBRIDS THEREOF | KOVALENKO, MYKOLA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19216147 | SEXUAL KENTUCKY BLUEGRASS CULTIVARS AND BREEDING STRATEGIES | STANKOVIC, BRATISLAV | — |
| 18232269 | HEXAPLOID-OCTOPLOID PERENNIAL RYEGRASS, HEXAPLOID-OCTOPLOID RYEGRASS AMERICAN RYEGRASS, AND HYBRIDS THEREOF | KOVALENKO, MYKOLA V | — |
| Art Unit | Apps |
|---|---|
| 1662 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19216147 | SEXUAL KENTUCKY BLUEGRASS CULTIVARS AND BREEDING STRATEGIES | STANKOVIC, BRATISLAV | 1662 | §101§102§112 | Non-Final OA | — | Pending | May 22, 2025 |
| 18232269 | HEXAPLOID-OCTOPLOID PERENNIAL RYEGRASS, HEXAPLOID-OCTOPLOID RYEGRASS AMERICAN RYEGRASS, AND HYBRIDS THEREOF | KOVALENKO, MYKOLA V | 1662 | §102§103§112 | Non-Final OA | — | Pending | Aug 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNexgen Plant Science Center LLC has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Bratislav Stankovic has the most, with 1 of Nexgen Plant Science Center LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
